FitzSimons, D. and Francois, Guido and Hall, A. S. and McMahon, B. and Meheus, A. and Zanetti, A. and Duval, B. and Jilg, Wolfgang and Bocher, W. O. and Lu, S. N. and Akarca, U. and Lavanchy, D. and Goldstein, S. and Banatvala, J. and Van Damme, P. (2005) Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants. VACCINE, 23 (32). pp. 4158-4166. ISSN 0264-410X, 1873-2518
Full text not available from this repository. (Request a copy)Abstract
The long-term efficacy of hepatitis B vaccine, long-term effectiveness of hepatitis B immunisation programmes, immune memory induced by hepatitis B vaccine, current booster policies, and impact of hepatitis B virus mutants on immunisation programmes were reviewed at the Viral Hepatitis Prevention Board (VHPB) meeting in Sevilla, Spain, March 2004. The main focus was on universal vaccination programmes with data being presented from Italy, Saudi Arabia, Singapore, Spain, Taiwan, Thailand, The Gambia, and USA (Alaska). (c) 2005 Elsevier Ltd. All rights reserved.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | 15-YEAR FOLLOW-UP; PROSPECTIVE RANDOMIZED-TRIAL; PLASMA-DERIVED VACCINE; INDUCED ESCAPE MUTANT; DNA YEAST VACCINE; ANTI-HBS; SURFACE-ANTIGEN; EXPANDED PROGRAM; HEPATOCELLULAR-CARCINOMA; MASS VACCINATION; hepatitis B; vaccine; long-term efficacy; booster policy; HBV mutants; vaccination programmes |
| Subjects: | 600 Technology > 610 Medical sciences Medicine |
| Divisions: | Medicine > Lehrstuhl für Medizinische Mikrobiologie und Hygiene |
| Depositing User: | Dr. Gernot Deinzer |
| Date Deposited: | 04 May 2021 10:58 |
| Last Modified: | 04 May 2021 10:58 |
| URI: | https://pred.uni-regensburg.de/id/eprint/35880 |
Actions (login required)
 |
View Item |
